Mary C Kuhns

Summary

Affiliation: Abbott Laboratories
Country: USA

Publications

  1. ncbi request reprint Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy
    Mary C Kuhns
    Abbott Laboratories, Abbott Park, Illinois, USA
    Transfusion 44:1332-9. 2004
  2. ncbi request reprint New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods
    Mary C Kuhns
    Abbott Diagnostics, Abbott Park, Illinois 60064, USA
    Mol Diagn Ther 10:77-91. 2006
  3. doi request reprint Correlation of improved hepatitis B surface antigen detection limits with hepatitis B virus DNA nucleic acid test yield in blood donations
    Lynn A Martin
    Abbott Diagnostics, Abbott Laboratories, Abbott Park, Illinois, USA
    Transfusion 52:2201-8. 2012
  4. ncbi request reprint HIV variants and hepatitis B surface antigen mutants: diagnostic challenges for immunoassays
    Gerald Schochetman
    Infections Disease Diagnostics, R and D, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL 60064, USA
    J Med Virol 78:S3-6. 2006
  5. ncbi request reprint Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening
    Steven H Kleinman
    Westat, Rockville, Maryland, USA
    Transfusion 43:696-704. 2003
  6. ncbi request reprint Surveillance of the genetic variation in incident HIV, HCV, and HBV infections in blood and plasma donors: implications for blood safety, diagnostics, treatment, and molecular epidemiology
    Eric Delwart
    Blood Systems Research Institute, and Department of Laboratory Medicine, University of California, San Francisco, California, USA
    J Med Virol 78:S30-5. 2006

Collaborators

Detail Information

Publications6

  1. ncbi request reprint Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy
    Mary C Kuhns
    Abbott Laboratories, Abbott Park, Illinois, USA
    Transfusion 44:1332-9. 2004
    ..Studies showing a significant correlation between hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) deoxyribonucleic acid (DNA) levels have focused on the HBV seroconversion window period...
  2. ncbi request reprint New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods
    Mary C Kuhns
    Abbott Diagnostics, Abbott Park, Illinois 60064, USA
    Mol Diagn Ther 10:77-91. 2006
    ..Each country will need to develop its blood screening strategy based on HBV endemicity, yields of infectious units detected by different serologic/NAT screening methods, and cost effectiveness of test methods in ensuring blood safety...
  3. doi request reprint Correlation of improved hepatitis B surface antigen detection limits with hepatitis B virus DNA nucleic acid test yield in blood donations
    Lynn A Martin
    Abbott Diagnostics, Abbott Laboratories, Abbott Park, Illinois, USA
    Transfusion 52:2201-8. 2012
    ....
  4. ncbi request reprint HIV variants and hepatitis B surface antigen mutants: diagnostic challenges for immunoassays
    Gerald Schochetman
    Infections Disease Diagnostics, R and D, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL 60064, USA
    J Med Virol 78:S3-6. 2006
  5. ncbi request reprint Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening
    Steven H Kleinman
    Westat, Rockville, Maryland, USA
    Transfusion 43:696-704. 2003
    ..An estimate of the rate of HBV DNA-positive, anti-HBc-positive units is important for evaluating the need for anti-HBc donor screening, especially in the context of HBV NAT...
  6. ncbi request reprint Surveillance of the genetic variation in incident HIV, HCV, and HBV infections in blood and plasma donors: implications for blood safety, diagnostics, treatment, and molecular epidemiology
    Eric Delwart
    Blood Systems Research Institute, and Department of Laboratory Medicine, University of California, San Francisco, California, USA
    J Med Virol 78:S30-5. 2006
    ..A systematic program is proposed for the genetic characterization of viral genomes in donors with incident HIV, HCV, or HBV infections...